Bayer, DE000BAY0017

Bayer stock after-hours at EUR 47.77: minus 2.61 percent versus prior close

Published on 09/30/2026 at 22:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer stock was at EUR 47.77 after-hours at 10:17 p.m. CEST on September 30, 2026, down 2.61 percent versus the Lang & Schwarz prior close. Bayer reported an FDA Priority Review on September 29.

Flatlay auf weißem Untergrund: weiße runde Tabletten, Marmorstößel, grünes Pflanzenblatt, Glasflakon und gedrucktes DNA-Doppelhelix-Diagramm; Beschriftungskarte mit Text PHARMA
Top-down-Arrangement: weiße Tabletten, Mörser, grünes Blatt, DNA-Diagramm, Beschriftungskarte PHARMA, Illustration mit AI erstellt.

Bayer stock was at EUR 47.77 after-hours at 10:17 p.m. CEST on September 30, 2026. The price was down 2.61 percent versus the prior close of EUR 49.05 at Lang & Schwarz.

After-hours trading

The Lang & Schwarz quote showed a minus EUR 1.28 change against the prior close. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Bayer stock.

FDA review for Lynkuet

On September 29, Bayer said the U.S. Food and Drug Administration had granted Priority Review to Lynkuet, also known as elinzanetant, for an additional indication. The proposed use covers moderate to severe vasomotor symptoms in women receiving endocrine therapy for hormone receptor-positive breast cancer, according to Bayer.

Earlier hybrid bond placement

Bayer’s newsroom also listed a September 23 placement of hybrid bonds totaling EUR 2.00 billion. The issuer described two tranches with non-call periods of six and nine years, according to Bayer.

Disclaimer...

en | DE000BAY0017 | BAYER | boerse | 70206537 | bgmi